3-Bromo-N1-methylbenzene-1,2-diamine, 95.0%, 250mg

5-bromo-1H-pyrazole-4-carboxylic acid, 98%, 250mg

1-(2-Amino-4-phenyl-1,3-thiazol-5-yl)ethanone, 95.0%, 2.5g

BENZYL 4-OXOSPIRO[CHROMAN-2,4'-PIPERIDINE]-1'-CARBOXYLATE, 95.0%, 250mg

7-Fluoro-4-oxo-4H-chromene-2-carboxylic acid, 95.0%, 1g

5-(3,5-Di-tert-butyl-4-hydroxybenzyl)thiazolidin-4-one, 98%, 50mg

(2R,3R)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate, 98%, 500mg

(2-((4-Methylpiperazin-1-yl)methyl)phenyl)boronic acid, 98%, 1g

(2E)-3-(4-fluorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(E)-1-(4-(Hexyloxy)-3-methylphenyl)-2-(4-(hexyloxy)phenyl)diazene, 95% HPLC, 1g

1-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,2,3,6-tetrahydropyridine, 96%, 250mg

Solution d'hydroxyde de sodium 5 %, extra pure, 2,5 l, emballage plastique.

N,N-DIMETHYLGLYCINE METHYL ESTER, 97.0%, 5g